Table 4 Interrelationships between clinicopathological characteristics of patients and protein expression/activation with renal cancer using χ2 analysis
From: Expression and prognostic significance of Src family members in renal clear cell carcinoma
Variable | Numbers | Age | T stage | Grade | Tumour necrosis (absence/presence) | Recurrence (no/yes) | Tumour volume (<10 cm3/>10 cm3) |
|---|---|---|---|---|---|---|---|
c-Src nuc (negative/positive) | 31/26 | 0.350 | 0.187 | 0.500 | 0.830 | 0.196 | 0.350 |
c-Src cyto (negative/positive) | 32/25 | 0.703 | 0.538 | 0.023 | 0.985 | 0.985 | 0.703 |
c-Src mem (negative/positive) | 29/28 | 0.148 | 0.205 | 0.916 | 0.363 | 0.021 a | 0.692 |
Y527 Src nuc (negative/positive) | 34/23 | 0.487 | 0.157 | 0.793 | 0.623 | 0.962 | 0.487 |
Y527 Src cyto (negative/positive) | 31/26 | 0.144 | 0.447 | 0.708 | 0.751 | 0.749 | 0.684 |
Y527 Src mem (negative/positive) | 29/28 | 0.026 | 0.335 | 0.916 | 0.882 | 0.358 | 0.513 |
Y416 Src nuc (negative/positive) | 29/28 | 0.692 | 0.889 | 0.916 | 0.227 | 0.701 | 0.513 |
Y416 Src cyto (negative/positive) | 32/25 | 0.227 | 0.056 | 0.443 | 0.985 | 0.289 | 0.083 |
Y416 Src mem (negative/positive) | 29/28 | 0.026 | 0.667 | 0.686 | 0.703 | 0.222 | 0.897 |
Y861 Fak nuc (negative/positive) | 29/28 | 0.897 | 0.478 | 0.482 | 0.703 | 0.701 | 0.692 |
Y861 Fak cyto (negative/positive) | 36/21 | 0.207 | 0.023 | 0.001 | 0.326 | 0.036 | 0.045 |
Y861 Fak mem (negative/positive) | 30/27 | 0.150 | 0.702 | 0.753 | 0.540 | 0.933 | 0.361 |
